Cole Eye Institute Retina Summit
Saturday, April 30, 2022
1:00 – 5:00 PM Local Time
Denver, Colorado
Join Us
The annual Cole Eye Institute Retina Summit will take place Saturday, April 30, 2022 prior to the ARVO Annual Meeting.
The summit will include didactic presentations and discussions focused on recent clinical study results and their application to clinical practice. The program will have interactive case-based sessions, with a dedicated audience question-and-answer session.
2021 Course Objectives
At the conclusion of this activity, participants will be able to:
- Diagnosis retinal diseases and assess treatment response using new and emerging imaging modalities
- Assess clinical evidence supporting approved therapeutics for retinal diseases
- Understand the role of biosimilar drugs in clinical practice
- Recognize the emerging role of port delivery systems
- Prepare for the entry of bispecific molecules and other emerging therapies for neovascular AMD and diabetic macular edema
- Detail how complement inhibitors may slow the growth of geographic atrophy
- Optimize retinal surgical outcomes through appropriate patient selection and use of retinal surgical systems
Target Audience
The Cole Eye Institute Retina Summit is for retina specialists, comprehensive ophthalmologists, retina fellows, and healthcare providers who are interested in applying the most recent advancements in retina.
Faculty
Peter K. Kaiser, MD
Educational Course Director
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Aleksandra Rachitskaya, MD
Educational Course Director
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Sunil K. Srivastava, MD
Educational Course Director
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Accreditation Information
|
|
|
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, and IVista. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
Evolve Medical Education designates this live activity for a maximum of 3 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an independent medical education grant from Alcon, Apellis Pharmaceuticals, and Bausch & Lomb.
Stay Informed
Can't make this event? Subscribe here to stay informed on all upcoming events!
